Bibliografía del artículo
1. Holdaway IM, Rajasoorya C. Epidemiology of acromegaly. Pituitary 2:29-41, 1999.
2. Chanson P, Salevane S, Kamenicky P et al. Acromegaly. Best Practice & Research Clinical Endocrinology & Metabolism 23: 555-574, 2009.
3. Colao A, Ferone D, Marzulio P et al. Systemic complications of acromegaly: Epidemiology, pathogenesis and management. Endocrine Reviews 25:102-105, 2004.
4. Donangelo I and MelmedShlomo. Treatment of Acromegaly. Endocrine 28:123-128, 2005.
5. Melmed S, Colao A, Barkan A, Molitch M et al.Guidelines for Acromegaly Management: An Update . J Clin Endocrinol Metab 94:1509-1517, 2009.
6. Jana Jezková, Josef Marek, VáclavHána et al. Gamma knife radiosurgery for acromegaly - long-term experience. Clinical Endocrinology 64:588-595, 2006.
7. Sociedad Mexicana de Nutrición y Endocrinología. Segundo consenso Nacional de Acromegalia. Revista de Endocrinología y Nutrición 15;S7-S16, 2007.
8. Martinez Delgado I , Gómez Martinez G. Acromegalia, Informe de 84 casos. Rev Med Inst Mex Seguro Soc 46(3):311-314, 2008.
9. Gómez Martinez G, Martinez Delgado IA. Tratamiento de acromegalia conoctreotida LAR en 42 casos. Rev Med Inst Mex Seguro Soc 48(1):39-45, 2010.
10. Maiza J, Vezzosi D, Matta M, Donadille F et al. Long term (up to 18 years ) effects on GH/IGF-1 hypersecretion and tumour size of primarusomatostatin analogue (SSTa) therapy in patienys with GH-secreting pituitary adenoma responsive to SSTa. Clinical Endocrinology 67:282-289, 2007.